Prescription Drug Abuse (Not Dependent)
9
0
0
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
63%
5 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (9)
Preventing Prescription Stimulant Diversion and Medication Misuse Via a Web-Based Simulation Intervention
Validation of a Community Pharmacy-Based Prescription Drug Monitoring Program Risk Screening Tool
Influence of Medication on Functional Connectivity
Linking Epigenomics With Prescription Opioid Abuse and High Impact Musculoskeletal Pain
Examining Expectancy Challenges to Prevent Nonmedical Prescription Stimulant Use
An Opioid Prescribing Nudge
Preventing Prescription Drug Abuse in Middle School Students
A Study of the Abuse Potential of Lasmiditan in Participants Who Are Recreational Drug Users
Mobile Application for Prescription Drug-Abuse Education (MAPDE)